Výsledky vyhledávání - "Ş. A. Bilgen"

AB0548 A COMPARATIVE STUDY BETWEEN THE NEUROPSYCHIATRIC INVOLVEMENTS IN ADULT-ONSET AND CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Autor: G. K. Yardimci, S. Sener, G. Ayan, A. Taghiyeva, N. P. Acar Ozen, E. D. Batu, L. Kiliç, H. İ. Öncel, A. Tuncer, R. Göçmen, K. Karli Oğuz, Y. Bilginer, U. Kalyoncu, S. Özen, Ş. A. Bilgen

Publikováno v: Annals of the Rheumatic Diseases. 81:1401-1402

BackgroundNeuropsychiatric(NP) manifestations in systemic lupus erythematosus(SLE) encompass a wide spectrum of neurologic and psychiatric features.The nervous system is frequently affected by adult-onset and childhood-onset SLE patients,but disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::720a2f16367778119970e9650c57cac8
https://doi.org/10.1136/annrheumdis-2022-eular.4319

Zobrazit plný text záznamu

POS0977 ASSOCIATION OF DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND AXIAL SPONDYLOARTHRITIS WITH THE M694V MUTATION

Autor: M. Kiraci, E. Bilgin, E. Duran, B. Farisogullari, E. C. Bolek, G. K. Yardimci, Z. Özsoy, G. Ayan, G. Sandal Uzun, T. H. Akbaba, B. B. Peynircioglu, O. Karadag, A. Akdoğan, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu, L. Kiliç

Publikováno v: Annals of the Rheumatic Diseases. 81:797.1-797

BackgroundThe incidence of co-occurrence of FMF and axial spondyloarthritis (axSpA) in adults is reported to be 0.5-7.5%. M694V mutation is the most frequent variant in patients with FMF+AxSpA (1).ObjectivesTo evaluate the association of demographic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6992e778a7c3b037c09322c4221a20ad
https://doi.org/10.1136/annrheumdis-2022-eular.2414

Zobrazit plný text záznamu

AB0353 bDMARD CHOICES FOR INFLAMMATORY ARTHRITIS WITH CHRONIC KIDNEY DISEASE; HUR-BIO REAL-LIFE REGISTRY

Publikováno v: Annals of the Rheumatic Diseases. 81:1303.1-1303

BackgroundRheumatic disesases may involve multiple systems and chronic kidney disease (CKD) can be seen during the course of diseases. Accompanying CKD affects the the choice of treatments in patients with rheumatic disease. There is limited data on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::863b5f8be08e0f9a675f13c039266f8d
https://doi.org/10.1136/annrheumdis-2022-eular.2474

Zobrazit plný text záznamu

AB0282 COMORBIDITIES ARE MORE IMPORTANT THAN JAK INHIBITORS: VENOUS THROMBOEMBOLISM IN RHEUMATOID ARTHRITIS

Autor: G. Sandal Uzun, M. Bahap, O. Yucel, Y. Kaygusuz, E. Bilgin, L. Kiliç, A. Akdoğan, O. Karadag, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu

Publikováno v: Annals of the Rheumatic Diseases. 81:1267.2-1268

BackgroundThe risk of Venous thromboembolisim (VTE) is increased and is an important cause of mortality and morbidity in rheumatoid arthritis. In addition to the underlying Rheumatoid arthritis(RA), there are a number of predisposing risk factors for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9dea3756a0c54f0a2ce0b8593b9d2b8
https://doi.org/10.1136/annrheumdis-2022-eular.3084

Zobrazit plný text záznamu

AB0940 Is psoriatic arthritis really seronegative?

Autor: G. Ayan, N. E. Gezerer, E. Bilgin, G. K. Yardimci, E. C. Bolek, B. Farisogullari, E. Duran, Z. Özsoy, G. Sandal Uzun, M. Ekici, E. Unaldi, L. Kiliç, A. Akdogan, O. Karadag, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu

Publikováno v: Annals of the Rheumatic Diseases. 81:1598.2-1599

BackgroundPsoriatic Arthritis (PsA) is a heterogeneous disease classified as a seronegative group of inflammatory arthritis.ObjectivesOur aim was to understand the real-life seropositivity rates for commonly used autoantibodies in rheumatology practi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96188e456cd39abe1baea15d80421a33
https://doi.org/10.1136/annrheumdis-2022-eular.2977

Zobrazit plný text záznamu

POS0991 PREDICTORS OF DEVELOPMENT OF ADVANCED SPINAL ANKYLOSIS/BAMBOO SPINE IN AXIAL SPONDYLOARTHRITIS: RESULTS FROM REAL-LIFE DATA

Autor: B. Farisogullari, G. K. Yardimci, E. Bilgin, E. C. Bolek, E. Duran, G. Ayan, Z. Özsoy, G. Sandal Uzun, M. Ekici, E. Unaldi, L. Kiliç, A. Akdoğan, O. Karadag, Ş. A. Bilgen, S. Kiraz, U. Kalyoncu, A. İ. Ertenli

Publikováno v: Annals of the Rheumatic Diseases. 81:803.2-804

BackgroundIn axial spondyloarthritis (axSpA), intervertebral ossification bridges of consecutive vertebrae may progress to advanced spinal ankylosis and bamboo spine over the years [1].ObjectivesTo identify demographic, clinical, disease activity and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c571e37aaa1a78fa9b86d5d68d47de5f
https://doi.org/10.1136/annrheumdis-2022-eular.3661

Zobrazit plný text záznamu

AB0275 THE FREQUENCY, PREVALENCE OF CORONARY ARTERY DISEASE AND PRE-MATURE CAD IN PsA AND RA PATIENTS

Autor: G. Ayan, G. Sandal Uzun, O. D. Tatar, N. E. Gezerer, E. Bilgin, G. K. Yardimci, E. C. Bolek, B. Farisogullari, E. Duran, Z. Özsoy, M. Ekici, E. Unaldi, L. Kiliç, A. Akdogan, O. Karadag, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu

Publikováno v: Annals of the Rheumatic Diseases. 81:1263.3-1264

BackgroundAn increased incidence of coronary artery disease (CAD) is known in inflammatory arthritis patients compared to the normal population. In the Veterans With Premature Atherosclerosis (VITAL) registry, the frequency of premature CAD (CAD < 55

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f20a056440ae133fcca8a19a8f8eb128
https://doi.org/10.1136/annrheumdis-2022-eular.2954

Zobrazit plný text záznamu

AB0277 DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING bDMARDs IS BETTER THAN PsA, BUT THERE IS STILL A WAY TO GO

Autor: G. Sandal Uzun, O. D. Tatar, N. E. Gezerer, E. Bilgin, G. K. Yardimci, E. C. Bolek, B. Farisogullari, E. Duran, Z. Özsoy, G. Ayan, M. Ekici, E. Unaldi, L. Kiliç, A. Akdoğan, O. Karadag, Ş. A. Bilgen, S. Kiraz, U. Kalyoncu, A. İ. Ertenli

Publikováno v: Annals of the Rheumatic Diseases. 81:1264.2-1265

BackgroundPatients with inflammatory arthritis have an increased risk of cardiovascular disease. Dyslipidemia is one of the primary modifiable risk factors.ObjectivesComparasion of the frequency of dyslipidemia and the use of anti-hyperlipidemic agen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0cff87454bce0d4282b81efac92ef02e
https://doi.org/10.1136/annrheumdis-2022-eular.3032

Zobrazit plný text záznamu

AB0843 OSTEOPOROSIS IN PATIENTS WITH SPONDYLOARTHRITIS: DO WE NEED TO DO MORE?

Autor: Z. Özsoy, K. Moral, F. Yeşil, E. Bilgin, E. C. Bolek, G. K. Yardimci, B. Farisogullari, E. Duran, G. Ayan, G. Sandal Uzun, M. Ekici, E. Unaldi, L. Kiliç, A. Akdoğan, O. Karadag, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu

Publikováno v: Annals of the Rheumatic Diseases. 81:1547.1-1547

BackgroundData regarding the prevalence and especially incidence of osteoporosis in Spondylarthritis (SPA) is scarce and very divergent among studies from different patient populations (1).ObjectivesIn this study, we aimed to compare demographic, dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::386b18f2ceca52c7b96ae70cf8218809
https://doi.org/10.1136/annrheumdis-2022-eular.3774

Zobrazit plný text záznamu

POS0944 PREDICTORS OF SUSTAINED REMISSION IN PEOPLE WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIOLOGIC DRUGS

Publikováno v: Annals of the Rheumatic Diseases. 81:776.1-776

BackgroundThe ultimate goal of treatment in axial spondyloarthritis (axSpA) is sustained remission. Data on predictors of sustained remission are scarce in axSpA.ObjectivesTo determine predictors of sustained remission in people with axSpA after trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f15b57cfab5f678a12976cbb743aef70
https://doi.org/10.1136/annrheumdis-2022-eular.3689

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání